Combination Efficacy with MetMAb and Erlotinib in a NSCLC Tumor Model Highlight Therapeutic Opportunities for C-Met Inhibitors in Combination with EGFR Inhibitors
Cancer Research（2008）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined